SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

Bachmann, MF; Mohsen, MO; Zha, LS; Vogel, M; Speiser, DE

Bachmann, MF (corresponding author), Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China.; Bachmann, MF (corresponding author), Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland.; Bachmann, MF (corresponding author), Univ Bern, Dept BioMed Res, Bern, Switzerland.; Speiser, DE (corresponding author), Univ Hosp, Lausanne, Switzerland.; Speiser, DE (corresponding author), Univ Lausanne, Lausanne, Switzerland.

NPJ VACCINES, 2021; 6 (1):

Abstract

Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structur......

Full Text Link